Travellers’ adherence to atovaquone/proguanil malaria chemoprophylaxis after return from endemic areas
Background: According to current guidelines, atovaquone/proguanil (AP) malaria chemoprophylaxis is taken once daily during travel, and continued for seven days after return from malaria-endemic areas. However, pharmacokinetic data and studies on drug-sparing AP regimens suggest that AP could possibl...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-03-01
|
Series: | Travel Medicine and Infectious Disease |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1477893925000183 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|